RxDoctor Payments DataLook up a doctor →

Asit Shah, MD

Orthopaedic Surgery · Englewood, NJNPI 1184676223

Payments from drug & device makers

$774,779in general payments, 2019–2025

Across 267 payments — averaging $2901.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Maxx Orthopedics, Inc.$698K
  • Stryker$41K
  • Guard Medical Inc.$31K
  • Smith+Nephew$3K
  • Johnson & Johnson$561
  • Kerecis Limited$472
  • plus $651 from 15 others
$100,000in research payments, 2019–2025

Across 2 payments — averaging $50,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Maxx Orthopedics, Inc.$100K

What the payments were for

  • Royalty or licence$205,19626%
  • Consulting fees$459,85759%
  • Travel & lodging$25,9883%
  • Food & beverage$19,2642%
  • Education$25,0003%
  • Other$39,4755%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$774,779 in reported general payments places this provider in the 95th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$685,276
Medicare patients
810
Services billed
6,479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl17$393
Gabapentin25$258
Meloxicam101$224
Celecoxib18$155
Oxycodone Hcl24$147
Amoxicillin38$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Englewood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →